Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR9Q2 Inhibitors

OR9Q2 is a member of the olfactory receptor family, which plays a critical role in the sense of smell. These receptors are part of a large class of proteins known as G protein-coupled receptors (GPCRs), which detect molecules outside the cell and trigger internal signal transduction pathways and cellular responses. The olfactory receptors, including OR9Q2, are predominantly expressed in the sensory neurons of the olfactory epithelium, where they are responsible for the detection of volatile chemical signals, which are interpreted by the brain as different odors. The specific function and the spectrum of odorants that OR9Q2 responds to are not well-characterized, as is the case with many olfactory receptors. However, understanding the regulation of the expression of genes such as OR9Q2 is crucial for comprehending how odors are perceived and processed by the olfactory system. A variety of chemicals can potentially downregulate or inhibit the expression of the OR9Q2 gene at the transcriptional or post-transcriptional level. One such compound is Actinomycin D, which binds to DNA and inhibits the transcription process by preventing RNA polymerase from effectively copying the OR9Q2 gene into messenger RNA. Another compound, Cycloheximide, functions by blocking the translation process, thus inhibiting protein synthesis, including that of OR9Q2. Similarly, Rapamycin targets the mTOR pathway, which is essential for protein synthesis and cell proliferation, potentially leading to a decrease in OR9Q2 expression. Histone deacetylase inhibitors like Trichostatin A and Sodium Butyrate modify chromatin structure, potentially affecting the accessibility of the OR9Q2 gene to the transcriptional machinery and thus altering its expression. Furthermore, compounds such as 5-Azacytidine and Mithramycin A can alter DNA methylation and DNA binding to transcription factors, respectively, each leading to potential reductions in OR9Q2 expression. These compounds illustrate the diverse molecular mechanisms through which chemical agents can regulate the expression of genes critical to olfactory function.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D binds directly to DNA, preventing RNA polymerase from initiating transcription, which would decrease OR9Q2 gene expression.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide blocks the elongation step of eukaryotic protein synthesis, leading to reduced synthesis of transcription factors critical for OR9Q2 expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

By inhibiting the mTOR signaling pathway, rapamycin decreases protein synthesis rates, which could lead to reduced transcription of OR9Q2.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A increases histone acetylation, changing chromatin structure to a state that may decrease accessibility of OR9Q2′s promoter for transcription factors.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine induces DNA demethylation, which could activate transcriptional repressors or silence enhancers associated with the OR9Q2 gene, thus reducing its expression.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin disrupts transcriptional activator interactions, potentially leading to decreased transcriptional initiation at the OR9Q2 locus.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol reduces the transcriptional activity of certain genes by altering promoter accessibility, potentially downregulating OR9Q2 expression.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium butyrate enhances histone acetylation, potentially leading to the suppression of transcriptional initiation complexes at the OR9Q2 gene.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic Acid represses the transcription of certain genes by binding to specific retinoic acid receptors that interact with the OR9Q2 promoter region, potentially decreasing its expression.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Mithramycin A binds selectively to DNA and inhibits the binding of transcriptional activators to the OR9Q2 promoter, thus decreasing its expression.